Holen Sie sich die Stockscreener-App
16.16
6.64%
-1.15
Handel nachbörslich:
16.13
-0.03
-0.19%
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Custom watchlist performance reports with Pulse Biosciences Inc.July 2025 Price Swings & Verified Momentum Stock Alerts - Newser
What makes Pulse Biosciences Inc. stock price move sharplyTrade Performance Summary & Low Drawdown Trading Techniques - thegnnews.com
When is the best time to buy Pulse Biosciences Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Price action breakdown for Pulse Biosciences Inc.Quarterly Investment Review & Long-Term Safe Return Strategies - Newser
Can you recover from losses in Pulse Biosciences Inc.Exit Point & Expert Approved Momentum Ideas - Newser
Smart tools for monitoring Pulse Biosciences Inc.’s price action2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
What high frequency data says about Pulse Biosciences Inc.2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
How moving averages guide Pulse Biosciences Inc. tradingJuly 2025 Chart Watch & Community Trade Idea Sharing Platform - Newser
How Interest Rate Changes Impact Pulse Biosciences Inc. Stock PerformanceJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Using flow based indicators on Pulse Biosciences Inc.July 2025 Patterns & Daily Technical Stock Forecast Reports - Newser
AI Tools Suggest Pulse Biosciences Inc. May Outperform This WeekJuly 2025 Decliners & Smart Swing Trading Techniques - metal.it
Pulse Biosciences Inc. Company Revenue and Profit Trends: A Deep Dive2025 Key Lessons & Safe Capital Allocation Plans - Newser
Short interest data insights for Pulse Biosciences Inc.Weekly Volume Report & Low Risk Entry Point Tips - Newser
Volume spikes in Pulse Biosciences Inc. stock – what they meanJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
What to expect from Pulse Biosciences Inc. in the next 30 daysMarket Sentiment Report & Weekly Top Performers Watchlists - Newser
Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs - MSN
Pulse Biosciences Reports Q2 2025 Earnings: Advancements in Clinical Programs and Strong Cash Position - AInvest
Pulse Biosciences shares surpass 200 DMA, rising 4.9% on Thursday. - AInvest
Pulse Biosciences (PLSE) Shares Cross Above 200 DMA - Nasdaq
Pulse Biosciences Inc. stock momentum explainedWeekly Trend Summary & Technical Entry and Exit Alerts - Newser
Will Pulse Biosciences Inc. see short term momentumBuy Signal & Verified Short-Term Plans - Newser
Competitive Positioning of Pulse Biosciences Inc.: Is It Leading or LaggingPortfolio Value Report & Accurate Trade Setup Notifications - Newser
Pulse Biosciences Surges 10.2% Amid Biotech Sector Turmoil: What's Fueling the Rally? - AInvest
Pulse Biosciences at Canaccord Conference: Strategic Expansion in Ablation By Investing.com - Investing.com Canada
Is it time to cut losses on Pulse Biosciences Inc.Long Setup & Real-Time Chart Breakout Alerts - Newser
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2025 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Cash Jumps in Q2 - AOL.com
Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... - Yahoo Finance
Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: N - GuruFocus
Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... By GuruFocus - Investing.com Canada
Pulse Biosciences Reports Q2 2025 Progress and Results - TipRanks
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences' Q2 2025: Unraveling Contradictions in Partnerships, R&D, and Clinical Strategies - AInvest
Pulse Biosciences Q2 2025 Earnings Call Transcript - MarketBeat
Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results - BioSpace
Pulse Biosciences Reports Q2 2025 Earnings, Outlines Percutaneous Electrode Revenue and IDE Milestones - AInvest
Evaluating Pulse Biosciences (PLSE) as a Speculative Play on Clinical Catalysts in nsPFA Technology - AInvest
Earnings call transcript: Pulse Biosciences Q2 2025 results show increased costs - Investing.com Nigeria
Transcript : Pulse Biosciences, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Pulse Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pulse Biosciences Q2 Loss Widens - MarketScreener
PULSE BIOSCIENCES Earnings Results: $PLSE Reports Quarterly Earnings - Quiver Quantitative
Pulse Biosciences Misses Q2 EPS Estimate by $0.02, Cash at $106.3M as of June 30. - AInvest
Can Pulse Biosciences Inc. be the next market leaderReal Profit Trade Tracker - newsyoung.net
Pulse Biosciences Inc. recovery potential after sell offTechnical Screener for High Growth Stocks - Newser
Best data tools to analyze Pulse Biosciences Inc. stockFree High Return Stock Focus With Safety - Newser
0.31%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):